intervention group for Acquired Immunodeficiency Syndrome

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Acquired Immunodeficiency Syndrome+4 More
mHealth - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test a new intervention to increase HIV, STI, and HCV testing among GBMSM and transgender women in rural Appalachia.

Eligible Conditions
  • Acquired Immunodeficiency Syndrome
  • Hepatitis C Virus (HCV) Infection
  • STI

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Acquired Immunodeficiency Syndrome

Study Objectives

6 Primary · 6 Secondary · Reporting Duration: baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline).

Month 24
Number of participants who have HCV testing
Number of participants who have HIV testing
Number of participants who have STI testing
baseline
Number of participants who have Hepatitis C Virus (HCV) testing
Number of participants who have Human Immunodeficiency Virus (HIV) testing
Number of participants who have Sexually Transmitted Infection (STI) testing
Month 24
Number of participants who use HCV treatment services
Number of participants who use HIV care services
Number of participants who use STI treatment services
Number of participants who use gender-affirming care services
Number of participants who use prevention--Pre-exposure prophylaxis (PrEP)
Number of participants who use prevention--syringe services

Trial Safety

Safety Progress

1 of 3

Other trials for Acquired Immunodeficiency Syndrome

Trial Design

2 Treatment Groups

intervention group
1 of 2
delayed-intervention
1 of 2
Active Control

141 Total Participants · 2 Treatment Groups

Primary Treatment: intervention group · No Placebo Group · N/A

intervention groupActiveComparator Group · 2 Interventions: mHealth, Peer Navigation · Intervention Types: Behavioral, Behavioral
delayed-interventionActiveComparator Group · 2 Interventions: mHealth, Peer Navigation · Intervention Types: Behavioral, Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline).

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,113 Previous Clinical Trials
1,129,528 Total Patients Enrolled
1 Trials studying Acquired Immunodeficiency Syndrome
186 Patients Enrolled for Acquired Immunodeficiency Syndrome
Scott D. Rhodes, Ph.D, MPHPrincipal InvestigatorWake Forest University Health Sciences

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are 18 years of age or older.
You live in one of the rural Appalachian counties.\n
You are provided with information about your test results.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 18th, 2021

Last Reviewed: October 25th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.